Athersys
ATHX
#10714
Rank
A$1.15 M
Marketcap
A$0.01879
Share price
-33.50%
Change (1 day)
-99.01%
Change (1 year)

Earnings for Athersys (ATHX)

Earnings in 2023 (TTM): -A$62.62 Million

According to Athersys's latest financial reports the company's current earnings are A$0.08 Million. In 2022 the company made an earning of -A$0.11 Billion, an increase over its 2021 earnings that were of -A$0.13 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Athersys from 2007 to 2023

Annual earnings

Year Earnings Change
2023 (TTM) -A$62.62 Million-41.6%
2022 -A$0.11 Billion-11.54%
2021 -A$0.13 Billion11.14%
2020 -A$0.11 Billion72.2%
2019 -A$63.33 Million77.29%
2018 -A$35.72 Million-22.91%
2017 -A$46.34 Million111.89%
2016 -A$21.87 Million-8.52%
2015 -A$23.91 Million-40.81%
2014 -A$40.4 Million18.62%
2013 -A$34.05 Million
2011 -A$19.19 Million19.71%
2010 -A$16.03 Million-26.28%
2009 -A$21.74 Million-18.21%
2008 -A$26.58 Million-8.28%
2007 -A$28.98 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
A$46.71 B-80,440.98%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
A$14.18 B-24,504.96%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
A$12.49 B-21,593.22%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
A$10.71 B-18,536.14%๐Ÿ‡ซ๐Ÿ‡ท France
Merck
MRK
A$31.21 B-53,792.35%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
A$12.98 B-22,436.10%๐Ÿ‡บ๐Ÿ‡ธ USA
United States Lime & Minerals
USLM
A$0.23 B-509.50%๐Ÿ‡บ๐Ÿ‡ธ USA
Moderna
MRNA
-A$3.84 Billion 6,504.09%๐Ÿ‡บ๐Ÿ‡ธ USA
Arena Pharmaceuticals
ARNA
-A$0.88 Billion 1,401.18%๐Ÿ‡บ๐Ÿ‡ธ USA